Search
Alvotech SA
ALVOAdd to Watchlist
3.920USD
+0.005+0.13%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
1.22BMarket Cap
40.68P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Alvotech SA is 7.33, ranking 297 out of 389 in the Biotechnology & Medical Research industry. The average price target is 9.75, with a high of 10.00 and a low of 5.00.
Analyst Rating
Based on
6
analysts
Buy
Current Rating
7.083
Target Price
+80.70%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
560
Total
5
Median
6
Average
Company name
Ratings
Analysts
Alvotech SA
ALVO
6
CRISPR Therapeutics AG
CRSP
27
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
1
2
3
...
112
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Alvotech SA's expected revenue for the next quarter?
Alvotech SA's expected revenue is 132.34M.
What is Alvotech SA's price target?
Analysts forecast that Alvotech SA's price target is USD 9.75, with the highest forecast at USD 10.00 and the lowest forecast at USD 5.00.
What is the analyst rating for Alvotech SA?
Based on the ratings of Alvotech SA's stock from 6 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
